This law provided incentives for pharmaceutical firms to develop new drugs for health problems that affected a relatively small number of people.

Question

Quizplus · Accepted Answer

The Orphan Drug Act, passed in 1983, provided incentives such as tax credits and exclusive marketing rights to pharmaceutical companies that develop drugs for rare diseases and conditions affecting fewer than 200,000 people in the US. This was done to provide a financial incentive for companies to invest in research and development of drugs for small patient populations, who might otherwise not have access to effective treatments.

This Law Provided Incentives for Pharmaceutical Firms to Develop New